PBRM1


Summary: This locus encodes a subunit of ATP-dependent chromatin-remodeling complexes. The encoded protein has been identified as in integral component of complexes necessary for ligand-dependent transcriptional activation by nuclear hormone receptors. Mutations at this locus have been associated with primary clear cell renal cell carcinoma. [provided by RefSeq, Feb 2012].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:606083
PHARMGKB IDPA162398846
Map Location3p21.1

Gene Categories:

CLINICALLY ACTIONABLE

GO terms in PBRM1


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IEA GO:0003677 DNA binding
MF IBA GO:0003682 chromatin binding
MF NAS GO:0003682 chromatin binding
MF IPI GO:0005515 protein binding
MF IBA GO:0015616 DNA translocase activity
BP TAS GO:0000278 mitotic cell cycle
Showing 1 to 6 of 17 rows rows per page

Gene expression in normal tissue: PBRM1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in PBRM1


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa05225 Hepatocellular carcinoma - Homo sapiens (human)
wikipathways WP4018 Pathways in clear cell renal cell carcinoma
reactome R-HSA-212436 Generic Transcription Pathway
reactome R-HSA-3214858 RMTs methylate histone arginines
reactome R-HSA-3247509 Chromatin modifying enzymes
reactome R-HSA-4839726 Chromatin organization
Showing 1 to 6 of 10 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD293 Bleomycin 1
iGMDRD310 Everolimus 1
iGMDRD907 EZH2 inhibitor 2
iGMDRD467 Motesanib 1
Showing 1 to 4 of 16 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in PBRM1

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​